Sven G Meuth Selected Research

Oligoclonal Bands

6/2020	MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
5/2020	Clinical, Radiological, and Laboratory Features of Spinal Cord Involvement in Primary Sjögren's Syndrome.
1/2020	Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sven G Meuth Research Topics

Disease

107	Multiple Sclerosis 01/2024 - 11/2007
28	Inflammation (Inflammations) 01/2023 - 08/2006
26	Relapsing-Remitting Multiple Sclerosis 01/2023 - 02/2011
24	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2022 - 09/2008
23	Neuroinflammatory Diseases 01/2023 - 09/2013
20	Stroke (Strokes) 01/2023 - 01/2009
19	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 11/2003
11	Neoplasms (Cancer) 01/2024 - 01/2012
10	Disease Progression 03/2024 - 09/2008
9	Ischemic Stroke 01/2020 - 04/2011
8	Progressive Multifocal Leukoencephalopathy 01/2021 - 01/2012
7	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 12/2011
7	Infections 08/2022 - 01/2012
7	Brain Ischemia (Cerebral Ischemia) 02/2014 - 10/2009
6	Myasthenia Gravis 04/2024 - 01/2022
6	Ischemia 06/2023 - 09/2010
6	Central Nervous System Diseases (CNS Diseases) 01/2023 - 09/2009
6	Lymphopenia (Lymphocytopenia) 01/2023 - 11/2013
6	Glioma (Gliomas) 01/2023 - 05/2008
6	Autoimmune Diseases of the Nervous System 03/2022 - 07/2017
6	Primary angiitis of the central nervous system 02/2022 - 01/2018
6	Hypoxia (Hypoxemia) 01/2021 - 05/2006
5	Seizures (Absence Seizure) 04/2024 - 09/2017
5	Epilepsy (Aura) 04/2024 - 09/2017
5	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2024 - 06/2016
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 07/2020
5	Atrophy 01/2023 - 07/2012
5	Neuromyelitis Optica (Devic's Disease) 12/2022 - 12/2016
5	Infarction (Infarctions) 12/2022 - 01/2009
5	Thrombosis (Thrombus) 10/2018 - 11/2012
4	Cognitive Dysfunction 04/2024 - 01/2017
4	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2016
4	Encephalomyelitis (Myeloencephalitis) 11/2022 - 07/2014
4	Absence Epilepsy (Childhood Absence Epilepsy) 10/2022 - 09/2007
4	Rheumatoid Arthritis 05/2021 - 02/2011
4	Leukocytosis (Pleocytosis) 06/2020 - 01/2020
4	Nervous System Diseases (Neurological Disorders) 05/2018 - 02/2009
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2014 - 01/2009
3	Brain Neoplasms (Brain Tumor) 12/2023 - 11/2015
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 10/2023 - 01/2022
3	Paralysis (Palsy) 10/2023 - 03/2011
3	Chronic Progressive Multiple Sclerosis 01/2023 - 02/2011
3	Ganglion Cysts (Ganglion) 01/2023 - 10/2018
3	Autoimmune limbic encephalitis 01/2023 - 12/2021
3	Virus Diseases (Viral Diseases) 02/2022 - 01/2021
3	COVID-19 01/2022 - 06/2020
3	Brain Diseases (Brain Disorder) 11/2021 - 06/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021 - 02/2014
3	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 07/2017

Drug/Important Bio-Agent (IBA)

24	Alemtuzumab (Campath)FDA Link 01/2023 - 01/2012
22	AntibodiesIBA 03/2024 - 11/2003
19	Natalizumab (Tysabri)FDA Link 01/2023 - 02/2011
18	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2011
17	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2008
14	CytokinesIBA 01/2023 - 11/2003
12	Potassium Channels (Potassium Channel)IBA 01/2022 - 05/2008
11	AutoantibodiesIBA 01/2023 - 01/2017
10	Myelin-Oligodendrocyte GlycoproteinIBA 10/2023 - 02/2010
9	AntigensIBA 01/2023 - 05/2009
9	CuprizoneIBA 10/2022 - 01/2016
8	Ion Channels (Ion Channel)IBA 04/2024 - 12/2011
8	Monoclonal AntibodiesIBA 01/2024 - 09/2008
8	Cladribine FDA LinkGeneric 01/2023 - 11/2020
7	Fingolimod Hydrochloride (FTY720)FDA Link 05/2022 - 11/2013
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2011
6	Retinaldehyde (Retinal)IBA 01/2023 - 09/2015
6	ocrelizumabIBA 01/2023 - 01/2021
6	Neuroprotective AgentsIBA 11/2022 - 11/2014
6	Rituximab (Mabthera)FDA Link 01/2022 - 12/2013
5	InterferonsIBA 03/2024 - 12/2018
5	Complement System Proteins (Complement)IBA 03/2024 - 10/2018
5	Peptides (Polypeptides)IBA 10/2023 - 08/2010
5	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2023 - 10/2020
5	CalciumIBA 01/2022 - 10/2009
5	Immunoglobulin G (IgG)IBA 01/2022 - 01/2016
4	Oxygen (Dioxygen)IBA 01/2023 - 01/2009
4	Glatiramer Acetate (Copaxone)FDA Link 01/2023 - 01/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 09/2017
4	N-acetyltalosaminuronic acid (NAT)IBA 01/2023 - 05/2017
4	Dimethyl FumarateIBA 02/2022 - 09/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
4	KininsIBA 11/2012 - 08/2010
3	Cholinergic ReceptorsIBA 04/2024 - 01/2017
3	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 03/2024 - 01/2020
3	PotassiumIBA 01/2023 - 12/2013
3	teriflunomideIBA 01/2023 - 01/2019
3	Interferon-betaIBA 01/2023 - 01/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2018
3	LigandsIBA 01/2023 - 12/2011
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 07/2017
3	Leucine (L-Leucine)FDA Link 01/2023 - 07/2022
3	Protein Isoforms (Isoforms)IBA 01/2023 - 10/2020
3	siponimodIBA 11/2022 - 11/2019
3	Ligases (Synthetase)IBA 10/2022 - 01/2021
3	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 10/2022 - 12/2013
3	SteroidsIBA 09/2022 - 04/2011
3	GadoliniumIBA 07/2022 - 06/2020
3	Amyloid (Amyloid Fibrils)IBA 09/2021 - 06/2012

Therapy/Procedure

60	Therapeutics 04/2024 - 11/2007
13	Immunotherapy 01/2023 - 12/2008